- Home
- ZNTL vs GAMB Comparison
ZNTL vs GAMB Comparison
Compare ZNTL & GAMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- GAMB
- Stock Information
- Founded
- ZNTL 2014
- GAMB 2006
- Country
- ZNTL United States
- GAMB Jersey
- Employees
- ZNTL N/A
- GAMB N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- GAMB Services-Misc. Amusement & Recreation
- Sector
- ZNTL Health Care
- GAMB Consumer Discretionary
- Exchange
- ZNTL Nasdaq
- GAMB Nasdaq
- Market Cap
- ZNTL 105.8M
- GAMB N/A
- IPO Year
- ZNTL 2020
- GAMB 2021
- Fundamental
- Price
- ZNTL $1.32
- GAMB $12.12
- Analyst Decision
- ZNTL Buy
- GAMB Strong Buy
- Analyst Count
- ZNTL 7
- GAMB 7
- Target Price
- ZNTL $8.60
- GAMB $17.00
- AVG Volume (30 Days)
- ZNTL 1.3M
- GAMB 352.7K
- Earning Date
- ZNTL 08-08-2025
- GAMB 08-14-2025
- Dividend Yield
- ZNTL N/A
- GAMB N/A
- EPS Growth
- ZNTL N/A
- GAMB 96.44
- EPS
- ZNTL N/A
- GAMB 0.96
- Revenue
- ZNTL $26,865,000.00
- GAMB $138,602,000.00
- Revenue This Year
- ZNTL N/A
- GAMB $38.03
- Revenue Next Year
- ZNTL N/A
- GAMB $11.98
- P/E Ratio
- ZNTL N/A
- GAMB $12.52
- Revenue Growth
- ZNTL N/A
- GAMB 24.67
- 52 Week Low
- ZNTL $1.01
- GAMB $8.01
- 52 Week High
- ZNTL $5.44
- GAMB $17.14
- Technical
- Relative Strength Index (RSI)
- ZNTL 50.56
- GAMB 51.99
- Support Level
- ZNTL $1.15
- GAMB $11.81
- Resistance Level
- ZNTL $1.39
- GAMB $12.17
- Average True Range (ATR)
- ZNTL 0.10
- GAMB 0.31
- MACD
- ZNTL -0.00
- GAMB 0.06
- Stochastic Oscillator
- ZNTL 45.12
- GAMB 87.97
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.